ExCEEd Orphan provides unique full business solution for biopharmaceutical companies launching their medicines in Central & Eastern Europe.
ExCEEd Orphan offers a unique blend of full CEE coverage (all 14 countries with total of 115mil. population) with strong local expertise and proven track record in gaining market access and launching multiple specialty medicines.
Our commitment to our clients is “To deliver your unique medicine to each and every patient by providing integral business solutions, fully compliant with your internal processes and local legal and regulatory requirements”
Everyone in our team has his or her own specialty and area of knowlegde.
Jiri Hermanek
Chief Executive Officer & Founding Partner
Education